Published in

Wiley, Journal of Medical Virology, 2(95), 2023

DOI: 10.1002/jmv.28522

Links

Tools

Export citation

Search in Google Scholar

The case fatality rate of COVID‐19 during the Delta and the Omicron epidemic phase: A meta‐analysis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractAs coronavirus variants are constantly occurring, we tried to understand more about the omicron and delta variants that have hit the world. We provided dynamic information on the case fatality rate (CFR) of the Omicron variant over time and to compare it with that of the Delta variant through meta‐analysis. Twenty‐four countries were selected by submission counts, submission dates, and confirmed cases. We defined the Delta or the Omicron epidemic period for individual countries as when each variant is over 90%. We further analyzed the Omicron period by dividing it into the initial plateau, increasing, and decreasing phases according to the number of newly confirmed daily cases. Finally, the meta‐analysis examined the summary and between‐study heterogeneity. The CFR of COVID‐19 during the Omicron epidemic was lower than that during the Delta epidemic (odds ratio [OR]: 0.252, 95% confidence interval [CI] 0.205−0.309). The CFR of COVID‐19 during the initial plateau phase of Omicron was higher than during other phases. (OR: 1.962, 95% CI 1.607−2.397). The CFR of COVID‐19 during the increasing phase was lower than during the decreasing phases (OR: 0.412, 95% CI 0.342–0.498). The Omicron variant had lower CFR compared to the Delta variant, and the initial plateau phase had higher CFR compared to the noninitial phases. These results can help establish global health policies for COVID‐19 in the future.